|1.||Campbell, D J: 3 articles (12/2001 - 04/2000)|
|2.||Pan, Jinhe: 2 articles (08/2015 - 01/2015)|
|3.||Amouroux, Guillaume: 2 articles (08/2015 - 01/2015)|
|4.||Lin, Kuo-Shyan: 2 articles (08/2015 - 01/2015)|
|5.||Jenni, Silvia: 2 articles (08/2015 - 01/2015)|
|6.||Hundal-Jabal, Navjit: 2 articles (08/2015 - 01/2015)|
|7.||Bénard, François: 2 articles (08/2015 - 01/2015)|
|8.||Hilgenfeldt, Ulrich: 2 articles (10/2008 - 07/2006)|
|9.||Liu, Zhibo: 1 article (08/2015)|
|10.||Zhang, Zhengxing: 1 article (08/2015)|
09/01/2009 - "In mammals, kallidin can be generated by the coronary endothelium and myocytes in response to ischemia, mediating cardioprotective events. "
01/01/2011 - "A fair amount of data indicates that bradykinin and lysyl-bradykinin exert arterial, cardiac and renal effects which afford protection against organ damage in diseases, especially in the settings of ischemia or diabetes. "
01/01/2015 - "Pharmacological induced increase of endogenous bradykinin and kallidin-like peptide levels in myocardium enhances cardiac tolerance to impact of ischemia/reperfusion. "
01/01/1989 - "The rank order of potency of several kinin analogues on the pain response was BK much much greater than sigma-cyclo-(Lys1-Gly6)-BK = sigma-cyclo-kallidin greater than des-Arg9-BK. "
12/01/1987 - "3. The rank order of potency of several kinin analogues on the pain response was BK much much greater than sigma-cyclo-(Lys1-Gly6)-BK = sigma-cyclo-kallidin greater than des-Arg9-BK. "
10/31/2008 - "Bradykinin and kallidin levels in the trapezius muscle in patients with work-related trapezius myalgia, in patients with whiplash associated pain, and in healthy controls - A microdialysis study of women."
02/01/1993 - "However, the pain response to 10% or 20% NaCl or the mild pain response to 50 or 500 nmol kallidin were unaffected by capsaicin pre-treatment. "
10/31/2008 - "Bradykinin (BKN) and kallidin (KAL) have been suggested to be algesic kinins involved in muscle pain. "
01/15/2015 - "In this study, we evaluated the feasibility of using radiolabeled kallidin derivatives to visualize B1R expression in a preclinical model of B1R-positive tumors. "
08/03/2015 - "Imaging Bradykinin B1 Receptor with 68Ga-Labeled [des-Arg10]Kallidin Derivatives: Effect of the Linker on Biodistribution and Tumor Uptake."
01/15/2015 - "While we found that radiolabeled peptides based on the native kallidin sequence were ineffective at visualizing B1R-positive tumors, peptidase inhibition with phosphoramidon greatly enhanced B1R visualization in vivo. "
01/01/2009 - "Both methionine-lysine-bradykinin and labradimil increased the blood half-life of Gd-DTPA sufficiently enough to increase significantly the tumor tissue Gd-DTPA area under the time-concentration curve. "
04/01/2015 - "Several other molecules, involved in cellular signaling, have since been shown to be targets for cathepsin X, such as γ-enolase, chemokine CXCL-12, bradykinin, kallidin, huntingtin and profilin 1. In cancer, cathepsin X regulates adhesion of tumor and endothelial cells and their migration and invasion through the extracellular matrix. "
|4.||Hypertension (High Blood Pressure)
01/01/1950 - "[Bradykinin, kallidin and hypertension]."
01/01/1977 - "Urinary kallikrein is an enzyme, probably originated in the kidney, which acts on plasma kininogen to produce kallidin, the decapeptide precursor of bradykinin, and appears to be implicated in various forms of arterial hypertension. "
01/25/2005 - "We measured angiotensin (Ang), bradykinin (BK), and kallidin peptides in subjects with essential hypertension administered placebo, losartan (50 mg OD), and eprosartan (600 mg OD) in randomized order in a double-blind, 3-period, 3-treatment, crossover trial. "
05/01/1965 - "[Study of the development of bradykinin- and kallidin-induced edema in the adrenalectomized rat. "
01/01/1994 - "The edema produced by the injection of carrageenan in rat hindpaws was associated with a sevenfold increase of immunoreactive kinins in the inflamed paw extract (from 0.021 +/- 0.007 to 0.141 +/- 0.021 pmol/g tissue; p < 0.01), the immunoreactivity corresponded to BK, kallidin, and T-kinin after HPLC separation. "
08/01/2005 - "The isolated protein, named natterin, was able to induce edema, nociception and cleave human kininogen and kininogen-derived synthetic peptides, releasing kallidin (Lys-bradykinin). "
|8.||Tissue Kallikreins (Tissue Kallikrein)
|2.||Drug Therapy (Chemotherapy)